TY - JOUR
T1 - Effects of morphine, in vitro and in vivo, on tyrosine hydroxylase activity in rat brain
AU - Cicero, Theodore J.
AU - Wilcox, Carol E.
AU - Smithloff, Ben R.
AU - Meyer, E. Robert
AU - Sharpe, Lawrence G.
N1 - Funding Information:
* This research was supported in part by USPHS Grants MH 20717 and MH 23048. t T.J.C. is a recipient of Research Scientist Development Award I-K2-MH 70180. 3237
PY - 1973/12/15
Y1 - 1973/12/15
N2 - The effect of morphine on the synthesis of catecholamines was determined in rat brain. In agreement with other studies, morphine produced a dose-dependent increase in the biosynthesis of the catecholamines. To assess whether morphine might enhance the synthesis of norepinephrine and dopamine by a direct chemical interaction with tyrosine hydroxylase, the rate-limiting step in their biosynthesis, the effects of the narcotic on the activity of the enzyme were determined in several regions of rat brain. Morphine, in vitro, from 10-8 to 10-2 M had no effect on the activity of tyrosine hydroxylase in any region examined. Moreover, morphine (10-5 and 10-3 M) had no effect on the apparent Km of tyrosine hydroxylase for either substrate or cofactor (6-7-dimethyl-5, 6,7,8-tetrahydropterine). In addition, morphine (10-5 and 10-3 M) failed to block the inhibition of tyrosine hydroxylase, in vitro, by norepinephrine and dopamine in the hypothalamus and caudate respectively. The effects of morphine treatment, in vivo, on enzyme activity were also examined. The results of these studies indicated that acute injections of morphine had no effect on tyrosine hydroxylase activity, in vitro, indicating that the drug did not alter the level of an endogenous activator or inhibitor of tyrosine hydroxylase. Further studies indicated that development of tolerance to and physical dependence on morphine was not associated with an increase in the activity of brain tyrosine hydroxylase activity. The results of these studies suggest that morphine does not enhance the biosynthesis of catecholamines by a direct effect of tyrosine hydroxylase and that tolerance to the narcotic is not characterized by an induction of this enzyme.
AB - The effect of morphine on the synthesis of catecholamines was determined in rat brain. In agreement with other studies, morphine produced a dose-dependent increase in the biosynthesis of the catecholamines. To assess whether morphine might enhance the synthesis of norepinephrine and dopamine by a direct chemical interaction with tyrosine hydroxylase, the rate-limiting step in their biosynthesis, the effects of the narcotic on the activity of the enzyme were determined in several regions of rat brain. Morphine, in vitro, from 10-8 to 10-2 M had no effect on the activity of tyrosine hydroxylase in any region examined. Moreover, morphine (10-5 and 10-3 M) had no effect on the apparent Km of tyrosine hydroxylase for either substrate or cofactor (6-7-dimethyl-5, 6,7,8-tetrahydropterine). In addition, morphine (10-5 and 10-3 M) failed to block the inhibition of tyrosine hydroxylase, in vitro, by norepinephrine and dopamine in the hypothalamus and caudate respectively. The effects of morphine treatment, in vivo, on enzyme activity were also examined. The results of these studies indicated that acute injections of morphine had no effect on tyrosine hydroxylase activity, in vitro, indicating that the drug did not alter the level of an endogenous activator or inhibitor of tyrosine hydroxylase. Further studies indicated that development of tolerance to and physical dependence on morphine was not associated with an increase in the activity of brain tyrosine hydroxylase activity. The results of these studies suggest that morphine does not enhance the biosynthesis of catecholamines by a direct effect of tyrosine hydroxylase and that tolerance to the narcotic is not characterized by an induction of this enzyme.
UR - http://www.scopus.com/inward/record.url?scp=0015714961&partnerID=8YFLogxK
U2 - 10.1016/0006-2952(73)90098-1
DO - 10.1016/0006-2952(73)90098-1
M3 - Article
C2 - 4149089
AN - SCOPUS:0015714961
SN - 0006-2952
VL - 22
SP - 3237
EP - 3246
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 24
ER -